ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lowered its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV) by 9.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,639 shares of the company’s stock after selling 4,716 shares during the period. Public Employees Retirement System of Ohio owned about 0.17% of ZimVie worth $420,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. MetLife Investment Management LLC raised its position in ZimVie by 8.0% during the second quarter. MetLife Investment Management LLC now owns 12,823 shares of the company’s stock worth $144,000 after acquiring an additional 952 shares during the last quarter. State of Wyoming raised its position in shares of ZimVie by 13.8% in the second quarter. State of Wyoming now owns 10,017 shares of the company’s stock valued at $112,000 after buying an additional 1,213 shares during the last quarter. Royal Bank of Canada raised its position in shares of ZimVie by 44.0% in the second quarter. Royal Bank of Canada now owns 4,681 shares of the company’s stock valued at $52,000 after buying an additional 1,430 shares during the last quarter. Lazard Asset Management LLC raised its position in shares of ZimVie by 13.3% in the third quarter. Lazard Asset Management LLC now owns 12,537 shares of the company’s stock valued at $117,000 after buying an additional 1,475 shares during the last quarter. Finally, Deutsche Bank AG raised its position in shares of ZimVie by 14.0% in the third quarter. Deutsche Bank AG now owns 13,179 shares of the company’s stock valued at $124,000 after buying an additional 1,620 shares during the last quarter. Institutional investors and hedge funds own 95.63% of the company’s stock.

Wall Street Analyst Weigh In

ZIMV has been the subject of a number of analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of ZimVie from $10.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, December 20th. Barclays boosted their price objective on shares of ZimVie from $13.00 to $16.00 and gave the company an “underweight” rating in a research report on Tuesday, March 5th.

ZimVie Price Performance

ZimVie stock opened at $16.31 on Thursday. ZimVie Inc. has a 1 year low of $6.46 and a 1 year high of $20.91. The firm has a 50 day moving average price of $17.99 and a 200 day moving average price of $13.56. The company has a market cap of $441.67 million, a price-to-earnings ratio of -1.10 and a beta of 2.21. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.32 and a current ratio of 2.78.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Wednesday, February 28th. The company reported $0.10 earnings per share (EPS) for the quarter. ZimVie had a negative net margin of 51.33% and a positive return on equity of 2.44%. The firm had revenue of $113.07 million during the quarter.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.